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Al~tract--Murine erythroleukaemia cells (MELC) are erythroid precursor cells that undergo erythroid 
differentiation in the presence of the inducer hexamethylene bisacetamide (HMBA). The effects of lead 
on haem biosynthesis in MELC following HMBA-induced differentiation were studied. MELC were 
induced with HMBA in the presence of 20, 40 and 80/aM-lead acetate and cell density, haem content, 
incorporation of ~4C-labelled 6-aminolaevulinic acid (ALA) into haem, and the activities of the enzymes 
6-aminolaevulinic acid dehydratase (ALA-D), uroporphyrinogen I synthetase (URO-S) and ferrochelatase 
(FERRO) were determined. MELC exposed to 80/~M-lead showed significant erythroid hypoplasia 
(40-50%) and a significant decrease (30-50%) in haem content at 2, 4 and 6 days after induction in 
comparison with the controls. Significant inhibition of ALA-D, the most sensitive index, was noted at 
20 ~UM-lead, and at 80/~M-lead ALA-D activity was decreased by 60-80°/, in comparison with the controls. 
URO-S and FERRO showed significant decreases of 34% and 50%, respectively, at 80/zM-lead. A 
decrease of 50% in the incorporation of [~4C]ALA into haem at 80/~M-lead indicated an impairment in 
haem synthesis. The results suggest that the impairment of haem formation by lead is coincident with the 
production of severe erythroid hypoplasia. 
INTRODUCTION 
Lead has long been known to exert toxic effects on 
the erythropoietic system that are associated with the 
development of anaemia. There is little information 
available concerning the regulation of haem bio- 
synthesis in the bone marrow associated with the 
development of anaemia following exposure to lead. 
Most previous studies concerning the aetiology of 
drug/toxicant-associated anaemia and its relationship 
to the biosynthesis of haem have been conducted with 
the mature red blood cell, which is not actively 
engaged in haem synthesis. Therefore, more relevant 
information is likely to be obtained by focusing study 
on the bone marrow rather than the red blood cell. 
Furthermore, controlled study of the role of various 
physiological (hormonal, nutritional) factors that 
regulate haem synthesis and/or influence the develop- 
ment of lead- or drug-associated anaemias is lacking. 
It is known that lead is preferentially deposited in 
bone marrow, and its concentration may reach 50 
times that in blood (Albahary, 1972). Consequently, 
bone marrow cells, particularly premature erythroid 
precursor cells, are most susceptible to the toxic 
effects of lead which can result in an anaemia charac- 
terized by erythroid hypoplasia (Sassa, 1978). 
*To whom correspondence should be addressed. 
Abbreviations: ALA = 6-aminolaevulinic acid; ALA-D = 
6-aminolaevulinic acid dehydratase; BPb = blood lead 
concentration; DTT = dithiothreitol; FERRO = ferro- 
chelatase, HMBA = hexamethylene bisacetamide; 
MELC = murine erythroleukaemia cells; MEM = 
minimum essential medium; PBG =porphobilinogen; 
PBGase = porphobilinogen deaminase; PBS = phos- 
phate buffered saline; URO-S=uroporphyrinogen ! 
synthetase. 
The haem biosynthetic pathway in erythroid tissue 
is a well known target for the toxic effects of lead 
(Bottomley and Muller-Eberhard, 1988). Lead has 
been shown to inhibit virtually all the enzymes of 
the pathway. 6-Aminolaevulinic acid dehydratase 
(ALA-D) is most sensitive to lead in vitro and in vivo, 
followed by ferrochelatase (FERRO), copropor- 
phyrinogen oxidase and porphobilinogen deaminase 
(PBGase, uroporphyrinogen I synthetase), respect- 
ively. Very high lead concentrations inhibit uropor- 
phyrinogen decarboxylase and di-aminolaevulinic 
acid synthase (Bottomley, 1977). 
As a result of the complex cellular heterogeneity of 
bone marrow in vivo, controlled study of this cellular 
target in the whole animal is rather difficult. There- 
fore, an in vitro system was used to study lead 
interactions and regulation of haem synthesis in 
erythroid precursor cells. The relative ease with which 
conditions can be manipulated in vitro makes it 
possible to study the role of various hormonal and 
nutritional factors that may regulate haem synthesis 
and/or influence the development of lead- or drug- 
associated anaemias. 
Murine erythroleukaemia cells (MELC) are a 
continuous cell line of erythroid precursor cells 
which, in the presence of certain chemicals such as 
dimethylsulphoxide and hexamethylene bisacetamide 
(HMBA), undergo changes similar to the normal 
maturation of red blood cells (Friend et al., 1971; 
Reuben et al., 1976). These changes include alter- 
ations in morphology, sequential induction of 
enzymes in the haem biosynthetic pathway with the 
production of haem and haemoglobin, expression of 
carbonic anhydrase activity, and the appearance of 
spectrin and red blood cell surface antigens (Marks 
and Rifkind, 1978). It is anticipated that MELC will 
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be a useful in citro model to study drug/toxicant 
interactions during erythropoiesis. 
In the studies described here we investigated the 
effects of lead on haem biosynthesis in MELC follow- 
ing HMBA-induced erythroid differentiation. The 
studies were designed to assess the ability of lead to 
(I) impair haem formation through a disruption in 
the normal maturation process and/or perturbation 
of selected enzymes m the haem biosynthetic 
pathway, and (2) to produce a state of erythroid 
hypoplasia in differentiating MELC). 
MATERIALS AND METHODS 
Cell culture. The murine erythroleukaemia cell line, 
clone 745A, derived from the DBA/2 mouse, was 
obtained from the NIGMS Human Genetic Mutant 
Cell Repository, Institute for Medical Research, 
(Camden, N J, USA). Cells were seeded at a final 
density of 5 x 105cells/ml in spinner flasks. Spinner 
cultures were maintained in an incubator at 37~C in 
medium consisting of Iscove's modified Dulbecco's 
minimum essential medium (MEM); Boehringer 
Mannheim Biochemicals, Indianapolis, IN, USA) 
supplemented with 5% (v/v) defined bovine calf 
serum (Hyclone Laboratories Inc., Logan, UT, 
USA). Induction of differentiation was achieved by 
addition of a stock solution (250mM) of HMBA 
(Sigma Chemical Co.. St Louis, MO, USA) to a final 
medium concentration of 3 raM. To assess the effects 
of lead, MELC were induced to differentiate in the 
continuous presence of 0 (control), 20, 40 or 80 p~-  
lead by appropriate freshly prepared dilutions in 
medium of a stock lead acetate solution in distilled 
deionized water (10 mM). Lead concentrations were 
chosen on the basis of solubility limits in culture 
medium and cell viability (trypan blue exclusion) 
during exposure periods. The actual lead concen- 
trations in medium were 19.5, 38.7 and 77.2pM as 
determined by atomic absorption spectrophotometry 
(Chemical Pathology, Department of Pathology, 
Medical School, University of Michigan, MI, USA). 
The lead concentration in control medium was below 
the limits of detection. Under all conditions, cell 
viability was >90%. Cultures were split every other 
day to 5 x 105cells/ml by dilution in fresh MEM 
containing HMBA and lead where appropriate. 
Unless stated otherwise, the following parameters 
were determined 2, 4 and 6 days after induction,' 
exposure as described below. 
Cell density and benzidine staining. Cell density was 
carried out using a haemocytometer. Cell doubling 
time was measured according to the method de- 
scribed by Patterson (1979). The percentage of 
haemoglobin-containing cells was determined at 6 
days by benzidine staining according to the method 
of Gopalakrishnan and Anderson (1979). A mini- 
mum of 500 cells were evaluated for each condition. 
Haem content. Haem content was measured by the 
microfluorometric method of Sassa (1976). Briefly, 
cell pellets were rinsed in phosphate buffered saline 
(PBS; pH 7.45) and heated in 2 M-oxalic acid for 
30 min at 100°C. Hemin (Sigma Chemical Co.) served 
as a standard and was heated similarly. After cooling, 
fluorescence was determined on an Aminco-Bowman 
Spectrophotofluorometer (American Instrument Co. 
Inc., Silver Spring, MD, USA). 
Subcellular fractionation. At the indicated times, 
MELC were collected by centrifugation at 100g 
for 10min and rinsed with PBS. The washed cell 
pellets (from control and lead-exposed MELC) were 
weighed and resuspended in three volumes of ice-cold 
distilled deionized water to lyse cells. These suspen- 
sions were homogenized manually with 15 strokes in 
a glass-teflon homogenizer and then adjusted to 
pH 7.8 by the addition of six volumes of 50 mM-Tris- 
HCI (pH 8.0). The homogenate was centrifuged at 
800g for 15min to remove cellular debris. The 
resulting supernatant was centrifuged at 9000g for 
20 min, yielding a mitochondrial pellet. This mito- 
chondrial pellet, washed and resuspended in 50 mM- 
Tris-HCl (pH 7.4), served as the enzyme source. The 
resulting 9000-g supernatant was centrifuged at 
100,000g for 60min to form the cytosolic fraction 
and the microsomal pellet. The cytosolic fraction 
served as the enzyme source. Protein content was 
determined by the method of Lowry et al. (1951) 
using bovine serum albumin as standard. 
Activities o f  haem biosynthetic enzymes. The 
activity of ALA-D was measured in MELC cytosol 
by the method of Gibson et al. (1955). The product, 
porphobilinogen (PBG), was measured spectrophoto- 
metrically (553 nm) after reaction with Ehrlich's 
reagent (Mauzerall and Granick, 1956). Spectro- 
photometric determination of PBG was carried out 
on an SLM Aminco DW-2000 UV-VIS Spectro- 
photometer (SLM Instruments Inc., Urbana, IL, 
USA) using a millimolar extinction coefficient of 61. 
Cytosolic uroporphyrinogen I synthetase (URO-S) 
was measured by a modification (Sassa et al., 1974) 
of the method of Strand et al. (1972). The cytosolic 
preparation was incubated with 100/~M-PBG (Por- 
phyrin Products, Logan, UT, USA) in 50 mM-Tris- 
HCI-50 mr, l-KC1 (pH 7.8) at 37 C for 45 min. The 
reaction was terminated by cooling tubes on ice and 
immediately adding ethyl acetate-acetic acid (2: 1, 
v/v). Then 1.0 N-HCI was added and the mixture 
was shaken vigorously. The phases were allowed to 
separate and stand for 30 min in room light. The 
porphyrin fluorescence in the lower aqueous phase 
was determined and compared to a uroporphyrin I 
standard (Porphyrin Products) using a spectrophoto- 
ftuorometer. 
Mitochondrial FERRO activity was measured by 
the pyridine haemochromagen method described by 
Dailey (1986). The assay measures the formation of 
deuterohaem from deuteroporphyrin IX (Porphyrin 
Products). Deuterohaem was quantitated by reduced 
minus oxidized difference spectra of its pyridine 
haemochrome by UV-visible spectrophotometry. For 
deuterohaem, a millimolar extinction coefficient 
(545-530 nm) of 15.3 was used. 
Microsomal haem oxygenase. Microsomal haem 
oxygenase activity was measured according to the 
method described by Tenhunen et al. (1968). 
Uroporphyrin I and III isomer composition. The 
composition of uroporphyrin isomers formed in the 
URO-S assay was analysed by HPLC as described by 
Rideout et al. (1983). Separations were carried out on 
a Waters Associates (Model 6000A) solvent delivery 
system interfaced to a Schoeffel (Model FS 970) 
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fluorometer equipped with a C18 bonded column 
(spherical 5/~m, 4.6-ram diameter x 22crn) from 
Brownlee Labs (Santa Clara, CA, USA), The mobile 
phase was 13% (v/v) acetonitrile in 1 M-ammonium 
acetate buffer (pH 5.16). 
DNA synthesis. DNA synthesis was measured as 
described by Friend et al. (1987). Cells were pulse 
labelled with [rnethyl-~H]thymidine (0.5 #Ci/ml; New 
England Nuclear, Boston, MA, USA) for l hr at 
37°C at 1, 3 and 5 days after induction/exposure (log- 
phase growth). The incorporation of [~H]thymidine 
into the acid insoluble fraction of cells was deter- 
mined by precipitation with 10% trichloroacetic acid 
at 5cC and collection of precipitates on Whatman 
3MM filter paper squares. Radioactivity was deter- 
mined by liquid scintillation spectrometry. 
Incorporation of  [s4C]ALA into haem. Incorpor- 
ation of ~4C-labelled 6-aminolaevulinic acid (ALA) 
into haern was measured by a modification of the 
method of Bonkowsky (1978). Cells were incubated 
with [~4C]ALA (0.17/aCi/ml; Amersham, Arlington 
Heights, IL, USA) for 24hr at 37°C. Cell pellets 
(8 × 106 cells) were reconstituted with ethyl acetate- 
acetic acid (4: 1, v/v; ferrous sulphate washed) with 
1 raM-heroin (Sigma Chemical Co.) added as carrier, 
and extracted with distilled deionized water and 
1 r~-HCI. ~4C radioactivity in the dried ethyl acetate 
residue (haem phase) was determined in a Beckman 
LS8000 scintillation spectrometer using Scinti-Verse 
BD (Fisher Scientific, Fair Lawn, N J, USA) as 
counting scintillant. The percentage recovery of 
carrier bemin was determined by the pyridine 
haemochromogen method (Falk, 1964) and found to 
be > 80% for both control and lead-treated cultures. 
Statistics. Student's t-test was used to compare 
differences in mean values between control and lead- 
exposed MELC cultures. 
RESULTS 
Cell density and benzidine staining 
MELC cultures exposed to 80/aM-lead showed 
significant erythroid hypoplasia (40--50% decreases in 
cell density) at 2, 4 and 6 days after induction/ 
exposure (Fig. 1). Cells were also greatly enlarged 
in comparison with control MELC, with cell lysis 
evident (data not shown). Average cell doubling time 
was also significantly increased at this lead concen- 
tration for all three time periods (18.36 + 2.02 hr for 
controls v. 28.04 + 1.86 hr for 80#M-lead exposed, 
P < 0.01). Cellular haemoglobin content was esti- 
mated by benzidine staining. Only MELC cultures 
exposed to 80 itM-lead showed a significant decrease 
(58% of control) in the percentage of benzidine 
positive cells at 6 days after induction/exposure 
(84.3 + 2.4% for controls v. 48.8 + 6.8% for 80/~ra- 
lead exposed, P < 0.01). 
naem content 
There was a progressive accumulation of haemo- 
globin-associated haem in control MELC after 
HMBA induction (Fig. 2). Only MELC exposed to 
80/aM-lead failed to show appreciable accumulation 
of haem over the 6-day period. In comparison with 
controls, there was a significant decrease in haem 
content in MELC exposed to 80/aM-lead at 2, 4 and 
6 days after induction/exposure and a slight but 
significant decrease in those exposed to 40 #M-lead at 
6 days. 
DNA synthesis 
There was a significant decrease (30-40%) in 
[3H]thymidine incorporation in MELC exposed to 
80/au-lead at I, 3 and 5 days after induction/ 
exposure (Table 1), consistent with the observed 
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Fig. I. Effect of lead exposure on cell density in hexa- 
methylene bisacetamide (HMBA)-induced cultures of 
murine erythroleukaemia cells (MELC). MELC were in- 
duced with HMBA in the presence of 0 (control; ~), 20 (1~1), 
40 (11) or 80 ( • )  /aM-lead acetate. Cell density was deter- 
mined at 2, 4 and 6 days after induction/exposure. Each bar 
represents the mean + SEM from twelve determinations, 
and asterisks denote a significant difference (Student's t-test) 
from the corresponding control value (*P <0.01; 
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Fig. 2. Effect of lead exposure on haem content in hexa- 
methylene bisacetamide-induced cultures of murine erythro- 
leukaemia cells (MELC). MELC were induced with HMBA 
in the absence or presence of 0 (control, O), 20 (~), 40 (111) 
or 80 ( m )  /aM-lead acetate. Haemoglobin-associated haem 
content was determined at 2, 4 and 6 days after induction/ 
exposure. Each bar represents the mean + SEM from nine 
determinations and asterisks denote significant difference 
(Student's t-test) from the corresponding control value 
(*P < 0.01; **P < 0.001). 
766 W . W .  Ku et al. 
Table I. Effect of lead exposure on lJH]thymidine incorporation into 
acid insoluble material in routine erythroleukaemia cells 
[JH]Thymidine incorporation (cpm/106 cells) 
Lead 
cohen (~M) Day I Day 3 Day 5 
0 (control) 1190 +_ 25 1150 ± 171 900+_ 28 
20 1148 +_ 57 919 +_ 41 735 ± 17 
40 1047 _+ 46 895 ± 31 776 +_ 29 
80 805 +_ 17" 690_+ II* 517 _+ 19" 
Values are the means ~ SEM from three determinations, and those 
marked with an asterisk differ significantly (Student's t-test) 
from the corresponding control value (*P < 0.05). 
p e r t u r b a t i o n s  in cell d e n s i t y  (Fig.  1) a n d  cell d o u b l i n g  
t ime.  
Table 3. Reversal of lead inhibition of fi aminolaevulinic dehydratase 
activity by inclusion of dithiothreitol and zinc in the incubation 
ALA-D activity 
(nmol PBG.'mg protein/hr) 
Lead Without % With % 
concn (#M)  DTT,'Zn 2. Control DTT/Zn 2+ Control 
0 (control) 39.7 +_ 1.8 - -  38.5 +_ 0.8 - -  
80 12.2+_0.4" 31 45.6+_0.4* 118 
ALA-D = 6-aminolaevulinic acid dehydratase 
DTT = dithiothreitol PBG = porphobilinogen 
DTT and ZnCI 2 were added at concentrations of 16 and 0.1 mM, 
respectively. 
Values are means -r- SEM for three determinations and those marked 
with asterisks differ significantly (Student's t-test) from the 
control value (*P < 0.001). 
Activities o f  haem biosynthetic enzymes and compo- 
sition o f  uroporphyrin isomers 
Inc rease s  in the  act iv i t ies  o f  the  h a e m  b i o s y n t h e t i c  
e n z y m e s  A L A - D ,  U R O - S  a n d  F E R R O  were  ob-  
se rved  in c o n t r o l  M E L C  fo l lowing  H M B A  i n d u c t i o n  
(Sassa ,  1976), wi th  m a x i m u m  levels o f  ac t iv i ty  
a t t a i n e d  a t  day  4 for  A L A - D  a n d  U R O - S  a n d  at  d a y  
6 for  F E R R O  (Tab le  2). F o l l o w i n g  lead e x p o s u r e ,  all 
th ree  e n z y m e s  s h o w e d  v a r y i n g  deg rees  o f  r educed  
ac t iv i ty  in c o m p a r i s o n  wi th  con t ro l s .  A s ign i f ican t  
dec r ea se  ( 3 0 - 4 0 % )  in A L A - D  act ivi ty ,  by far  the  
m o s t  sens i t ive  index  o f  lead e x p o s u r e ,  was  n o t e d  at 20 
a n d  40 /aM-lead  a n d  on l y  2 0 - 4 0 %  o f  c o n t r o l  ac t iv i ty  
was  o b s e r v e d  for  M E L C  e x p o s e d  to 80 pM-lead .  T h e  
p r o f o u n d  inh ib i t i on  in A L A - D  ac t iv i ty  n o t e d  at  
8 0 p M - l e a d  cou ld  be reversed  by r eac t i va t i on  u s i n g  
z inc  a n d  d i t h io th r e i t o l  ( D T T )  in the  a s s a y  i n c u b a t i o n  
(Tab le  3) as  r epo r t ed  by o t h e r s  (Finell i  et al., 1975; 
Ge i s s e  et al., 1983; T z u k a m o t o  et al., 1979). U R O - S  
ac t iv i ty  was  s ign i f ican t ly  dep re s sed  (66% o f  c o n t r o l  
ac t iv i ty)  on ly  a f te r  e x p o s u r e  to 80 pM-lead  a n d  a t  4 
d a y s  a f te r  i n d u c t i o n .  M E L C  e x p o s e d  to 40 o r  80 pM- 
lead s h o w e d  no  s ign i f ican t  d i f fe rences  f r o m  c o n t r o l s  
in the  p r o p o r t i o n s  o f  u r o p o r p h y r i n  I a n d  I l l  i s o m e r s  
f o r m e d  in the  U R O - S  a s s a y  (Fig.  3). A s ign i f ican t  
dec rease  (50--60% o f  c o n t r o l  ac t iv i ty)  in F E R R O  was  
o b s e r v e d  on ly  in M E L C  e x p o s e d  to 8 0 p M - l e a d .  
Table 2. Effect of lead exposure on selected haem biosynthetic 
enzymes in murine erythroleukaemia cells 
Enzyme activity+ 
Lead 
Day concn (,aM) ALA-D URO-S FERRO 
2 0 (control) 40.2 -- 1.4 5.6 ~- 0.7 3.8 -+ 0.4 
20 25.2 + 1.9"* 5.5 ± 0.5 3.4 + 0.1 
40 26.0-- 1.6"* 6.1 --0.4 3.3_+0.3 
80 17.2+_ 1.2"* 5.1 +_0.5 1.7__0.2" 
4 0 (control) 60.2 +_ 6.0 8.8 +_ 0.6 3.9 -- 0.7 
20 33.8 _+ 2.4** 9.3 _+ 0.6 3.7 _+ 0.6 
40 28.6 +_ 1.3"* 8.3 +_ 0.4 3.7 ~- 0.3 
80 13.1 --0.9** 5.8--0.5* 2.4+_0.4* 
6 0 (control) 61.9 +_ 6.3 9.0 +_ 1.3 5.9 -I" 0.3 
20 36.3 _* 1.2"* 9.5 ~ 1.3 5.7 +_ 0.7 
40 31.3+1.1"* 9.0_+1.4 4.1 ~ 0.6 
80 13.8+0.8"* 7.1 + 1.0 3.2 +_0.9* 
ALA-D = di-aminolaevulini¢ acid dehydratase 
URO-S = uroporphyrinogen I synthetase 
FERRO = ferrochelatase 
÷ALA-D: nmol porphobilinogen formed/rag protein,'hr; URO-S: 
nmol uroporphyrinogen formed/rag protein.'45 rain; FERRO: 
nmol deuterohaem formed/rag protein/hr. 
Values are means + SEM from three determinations and those 
marked with asterisks differ significantly (Student's t-test) from 
the corresponding control value (*P < 0.05; **P < 0.01). 
Microsomal haem oxygenase 
T h e  ac t iv i ty  o f  m i c r o s o m a l  h a e m  o x y g e n a s e  was  
f o u n d  to be n o n - d e t e c t a b l e  a n d  n o n - i n d u c i b l e  by lead 
e x p o s u r e  in M E L C  (da t a  no t  shown) .  
Incorporation o f  [14C]ALA into haem 
T h e  effect o f  lead e x p o s u r e  on  h a e m  syn the s i s  was  
i nves t i ga t ed  by m e a s u r e m e n t  o f  [~4C]ALA i n c o r p o r -  
a t i on  in to  h a e m .  M a x i m u m  levels o f  [~4C]ALA incor -  
p o r a t i o n  in to  h a e m  were o b s e r v e d  in con t ro l  M E L C  
be tween  d a y  3 a n d  d a y  5 a f te r  H M B A  i n d u c t i o n  
(Fig.  4). M E L C  e x p o s e d  to 80/1M-lead s h o w e d  sig- 
n i f icant  dec rease s  ( 5 0 % )  in [~4C]ALA i n c o r p o r a t i o n  
d u r i n g  th is  t ime  per iod .  T h e s e  resu l t s  were c o n s i s t e n t  
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Fig. 3. Effect of  lead exposure on the isomeric composition 
of  uroporphyrinogen formed in hexamethylene bisacetamide- 
induced cultures of  murine erythroleukaemia cells (MELC). 
MELC were induced with HMBA in the absence or presence 
of  lead acetate. The proportions of  uroporphyrin isomers I 
and 111 formed in the uroporphyrinogen I synthetase assay 
at 2 (O),  4 (O)  and 6 (&) days after induction/exposure 
were determined by HPLC. Values represent the percentages 
of  uroporphyrin I and III formed +__ SEM from six 
determinations. 
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Fig. 4. Effect of lead exposure on the incorporation of 
~'C-labelled 6-aminolaevulinic acid ([~'CIALA) into haem in 
hexamethylene bisacetamide-induced cultures of murine 
erythroleukaemia cells (MELC). MELC were induced with 
HMBA in the absence ([-1) or presence of lead acetate 
(80 ~M; ~). The incorporation of [t'C]ALA into haem at 
24-hr intervals between day I and day 5 was measured as 
described in Materials and Methods. Values represent the 
mean incorporation + SEM from four determinations, and 
an asterisk denotes a significant difference (Student's t-test) 
from the corresponding control value (*P < 0.001). 
with the lack of appreciable haem accumulation 
noted for this lead concentration (Fig. 2). 
DISCUSSION 
Previous studies of erythropoiesis using bone 
marrow cells in t'itro have been complicated by the 
contamination of the erythroid cellular component 
with myeloid and stromal elements and the lack of 
adequate control over the maturation program of 
erythroid precursors (Allen and Dexter, 1983; Dexter, 
1979). MELC are a clonal cell line of erythroid 
precursors whose maturation program can be con- 
trolled by the addition of soluble polar chemicals 
such as dimethylsulphoxide or HMBA (Marks and 
Rifkind, 1978) and we have used them to study 
the effects of lead on erythroid cell growth and 
maturation and the synthesis of haem. 
The results showed a significant decrease in the 
accumulation of haemoglobin-associated haem only 
in MELC exposed to 80 pM-lead following induction 
of differentiation with HMBA. However, this 
decrease in haem content was accompanied by cell 
enlargement, cell lysis and significant erythroid hypo- 
plasia, with subsequent disruptions in DNA synthesis 
and cell doubling time. The data demonstrated that 
the impairment by lead of haem formation in MELC 
was coincident with the production of a severe 
erythroid hypoplasia with haemolytic changes. 
With respect to cases of human lead exposure, it is 
rather difficult to assess the relationship between 
the concentration of lead required to impair haem 
synthesis in this in vitro system with that which might 
be attainable in humans, by either general or occu- 
pational exposure, because most of the data for 
humans are expressed in terms of lead concentration 
in blood (BPb), not in bone marrow, although bone 
marrow is the major site of haem synthesis. It has 
been estimated that the concentration of lead in 
bone and marrow is 50-80 times that in the blood 
(Albahary, 1972; Baloh, 1974; Flood et  al., 1988; 
Gross et al., 1975), with normal BPb levels ranging 
between 20 and 40/~g/100 ml. However, a subsequent 
long-term survey has revealed that BPb levels in US 
adults have been declining to a value of around 
10 pg/100 ml (Annest, 1983). In cases of occupational 
lead poisoning, BPb values may exceed 80/~g/100 ml 
(Brangstrup Hansen et al., 1981). Lead in bone and 
marrow is distributed among the cellular components 
(erythroid precursors, myelocytes, granulocytes) as 
well as the mineralized bone matrix itself. Recent 
studies using laser microbeam mass analysis to assess 
lead distribution on the subcellular level suggest that 
lead is three to ten times more concentrated in nuclei 
than in the cytoplasm of bone marrow cells (Flood et 
al., 1988). Using the data obtained from an individual 
with severe lead poisoning, a crude estimation of the 
concentration of lead in the cytoplasm of all bone 
marrow cell types lies between 20 and 60/aM. Unfor- 
tunately, Ca-EDTA chelation therapy had com- 
menced in this individual before the measurements 
were taken. In the in vitro system described here, only 
the erythroid cellular component of marrow was 
exposed to lead. Thus, until further data become 
available, it remains uncertain whether the erythroid 
element of bone marrow in vivo would be exposed to 
the concentration of lead that was required to impair 
haem synthesis in this in ri tro system. 
The effect of lead exposure on haem formation in 
MELC was determined by evaluating the activities of 
selected enzymes in the haem synthetic pathway and 
the incorporation of [~4C]ALA into haem. In the 
haem synthetic pathway, the activity of ALA-D was 
most sensitive to lead, followed by FERRO and 
URO-S, respectively, with the latter two showing 
significant decreases only at 80/aM-lead. A significant 
depression in the activity of ALA-D has been 
reported in rat whole bone marrow cell suspensions 
with exposure to as low as 0.5/z M-lead (Dresner et al., 
1982). However, it is difficult to compare their results 
with ours because of the differences both in lead 
exposure conditions and methods of cell culture. No 
effect of lead exposure was noted in the proportion of 
uroporphyrinogen I and III isomers formed in the 
URO-S assay. Levels of haem were depressed only 
under conditions in which the activities of all three 
enzymes studied were decreased. Furthermore, de- 
creases in the activity of ALA-D of up to 50% could 
occur without any significant decrease in haem con- 
tent. This observation is analogous to that in humans. 
ALA-D activity is negatively correlated with BPb 
concentration in the general population (Lolin and 
O'Gorman, 1986; Secchi and Alessio, 1974; Waldron, 
1974), and is impaired by BPb levels well within 
the range of values found in individuals with only 
environmental exposure. It is believed that since the 
reserve capacity of ALA-D is large, its inhibition at 
low BPb levels is not likely to interfere with haem 
synthesis (Waldron, 1974). 
It has been suggested that lead's effect on haem 
synthesis most probably involves interference with a 
number of enzymes in the haem synthetic pathway. In 
humans, decreases in erythrocyte URO-S are not 
often observed in lead poisoning (Campbell et al., 
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1977; El-Waseef, 1982), although lead-associated 
decreases are observed when 5-aminolaevulinic acid 
is used as substrate rather than porphobilinogen 
(El-Waseef, 1982; Ford et al., 1980), suggesting that 
substrate deprivation through inhibition of ALA-D 
plays a role in impairing subsequent synthesis of 
uroporphyrinogen. Using porphobilinogen as sub- 
strate, URO-S showed the least extent of inhibition 
by lead in the in vitro system described here, with 
no effect on the composition of uroporphyrinogen 
isomers formed. The relative lack of sensitivity of 
uroporphyrinogen synthesis to lead inhibition may be 
explained by the fact that, in this system as well as in 
liver, this step is well protected by a low-molecular- 
weight, heat-stable factor (Ku and Piper, 1990; Piper 
and van Lier, 1977). 
The activity of FERRO was significantly affected 
by the highest concentration of lead used in our /n 
t'itro system. In lead poisoning in humans, profound 
depression in the activity of FERRO, measured by 
either the percentage of 59Fe uptake into haem or the 
level of erythrocyte protoporphyrin, has been ob- 
served (Campbell et al., 1977; Lubran, 1980; Piomelli 
et al., 1982; Rogan et al., 1986). As for other enzymes 
in the haem synthetic pathway, Campbell et al. (1977) 
reported marked elevation of ALA synthase, normal 
uroporphyrinogen decarboxylase and depressed co- 
proporphyrinogen oxidase as common features of 
lead poisoning in addition to the enzyme changes 
previously mentioned. In our in t'itro system, the 
activities of these enzymes were not determined. 
The question may be raised as to whether increases 
in haem catabolism could explain the decrease 
in haem content at 80/~M-lead. However, haem 
oxygenase activity was found to be extremely low and 
non-inducible by lead exposure in MELC. Further- 
more, a lead-associated disruption in the ability to 
synthesize haem was confirmed by the decreased 
incorporation of [~4C]ALA into haem that was noted 
in MELC exposed to 80/~M-lead. 
Overall, the data are consistent with the suggestion 
that a lead-associated disruption in haem synthesis 
involves interference with a number of enzymes in the 
haem synthetic pathway, and that this disruption is 
accompanied and complicated by severe erythroid 
hypoplasia. Apart from the question of the lead 
concentrations used, the in vitro system described 
here provides a useful model to study the regulation 
of haem synthesis, isomer composition of haem 
intermediates, and drug/toxicant interactions during 
erythropoiesis. Furthermore, by manipulation of the 
tissue culture environment, it is possible to identify 
the role of various hormonal and nutritional factors 
that regulate haem synthesis and/or influence the 
development of lead- or drug-associated anaemia. 
In our laboratory, a major interest is the role of 
polyglutamated folate derivatives that protect against 
inhibition of URO-S by lead (Ku and Piper, 1990; 
Piper and van Lier, 1977). Most importantly, the 
use of the MELC technique to evaluate the poten- 
tial of commercial and/or therapeutic products to 
impair haem formation and/or interfere with normal 
erythroid development should refine conditions to 
study the basic underlying mechanism of action in 
the absence of complicating factors encountered 
in rivo. 
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